1. Home
  2. PAVS vs CTMX Comparison

PAVS vs CTMX Comparison

Compare PAVS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paranovus Entertainment Technology Ltd.

PAVS

Paranovus Entertainment Technology Ltd.

HOLD

Current Price

$1.28

Market Cap

1.3M

Sector

Health Care

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$5.71

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAVS
CTMX
Founded
2004
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3M
596.2M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
PAVS
CTMX
Price
$1.28
$5.71
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
1.3M
3.7M
Earning Date
08-04-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$12,416,127.00
$113,631,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$23.67
Revenue Growth
18037.91
N/A
52 Week Low
$1.08
$0.40
52 Week High
$150.00
$6.35

Technical Indicators

Market Signals
Indicator
PAVS
CTMX
Relative Strength Index (RSI) N/A 54.53
Support Level N/A $5.17
Resistance Level N/A $6.35
Average True Range (ATR) 0.00 0.50
MACD 0.00 -0.05
Stochastic Oscillator 0.00 29.01

Price Performance

Historical Comparison
PAVS
CTMX

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: